An adjuvanted, #trivalent #influenzavaccine developed by #CSLSeqirus and recently approved in the #UK, #Aujemflu, will be deployed ahead of the 2027/28 #fluseason under an agreement with the government.

pharmaphorum.com/news/uk-firs...